Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).
The synucleinopathy known as idiopathic Parkinson's disease (IPD) is a multi-system disorder in the course of which only a few predisposed nerve cell types in specific regions of the human brain become progressively involved. The underlying neuropathological process (formation of proteinaceous intraneuronal inclusion bodies) intracerebrally begins in clearly defined induction sites and advances in a topographically predictable sequence. Components of the autonomic, limbic, and motor systems sustain especially heavy damage. During the presymptomatic stages 1 and 2, the IPD-related inclusion body pathology remains confined to the medulla oblongata and olfactory bulb. In stages 3 and 4, the substantia nigra and other nuclear grays of the midbrain and basal forebrain are the focus of initially subtle and, then, severe changes. The illness reaches its symptomatic phase. In end-stages 5 and 6, the pathological process encroaches upon the telencephalic cortex. IPD manifests itself in all of its dimensions, which under the influence of the supervening cortical pathology are subject to increasing complexity.
Braak
Heiko
H
Institute for Clinical Neuroanatomy, J.W.Goethe University, Frankfurt/Main, Germany. Braak@em.uni-frankfurt.de
Del Tredici
Kelly
K
Bratzke
Hansjürgen
H
Hamm-Clement
John
J
Sandmann-Keil
Daniele
D
Rüb
Udo
U
D001341:Autonomic Nervous System / Q000473:pathology; D001921:Brain / Q000473:pathology*; D002540:Cerebral Cortex / Q000473:pathology; D018450:Disease Progression; D006801:Humans; D016631:Lewy Bodies / Q000473:pathology*; D008032:Limbic System / Q000473:pathology; D008526:Medulla Oblongata / Q000473:pathology; D009830:Olfactory Bulb / Q000473:pathology; D010300:Parkinson Disease / Q000473:pathology* / Q000503:physiopathology; D012720:Severity of Illness Index; D013378:Substantia Nigra